Celebrex(Celecoxib)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$13.7M
Medicare cost, 2024
$13.7M
Medicare cost, 2024
Medicare drug plans spent $13.7 million on Celebrex (celecoxib) in 2024, for 11,908 prescriptions and refills filled by 3,369 patients. Spending fell 15% from 2023 to 2024. California accounts for the most spending ($1.6 million, 12% of the total).
Medicare cost, 2024
$13.7M
-15.1% from 2023
Prescriptions
12K
$1,154.46 per claim
Patients
3,369
3,709 prescribers
Total spending, 2024
$13.8M
$4,081.92 per patient
Questions and answers
How much does Medicare spend on Celebrex?
Medicare prescription drug plans paid $13.7M for Celebrex in 2024, for 11,908 prescriptions and refills to 3,369 patients (down 15.1% from 2023). The average cost per claim was $1,154.46.
Which state spends the most on Celebrex?
California had the highest Medicare cost for Celebrex in 2024: $1.6M for 1,379 claims, followed by New York ($1.2M).
Who prescribes Celebrex the most?
Rita Goldvug, internal medicine in Rego Park, NY, had the highest Medicare cost for Celebrex in 2024: 41 claims costing $36K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Celebrex was $13.8M in 2024, after a high of $27.3M in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Celebrex, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rita Goldvug Rego Park, NY | Internal Medicine | 41 | Under 11 | $36K |
| Srikanth Naramala Visalia, CA | Rheumatology | 18 | 13 | $29K |
| Isaac B Snapp Darlington, SC | Physician Assistant | 22 | Under 11 | $24K |
| Derrick M Brown Holmdel, NJ | Internal Medicine | 22 | Under 11 | $21K |
| Mariko Ishimori Los Angeles, CA | Rheumatology | 27 | Under 11 | $19K |
| Michael Barrett Lamar, SC | Family Practice | 19 | Under 11 | $18K |
| Anthony A Depaola Branchville, NJ | Internal Medicine | 12 | Under 11 | $18K |
| Luisana Gomez Monterey Park, CA | Physician Assistant | 12 | Under 11 | $18K |
| Michelle Cleeves Denver, CO | Internal Medicine | 12 | Under 11 | $18K |
| Jennifer A Shockley Elk Rapids, MI | Family Practice | 13 | Under 11 | $17K |
| Gerald Y Ho La Palma, CA | Rheumatology | 11 | Under 11 | $17K |
| Joshua Levy Sherman Oaks, CA | Rheumatology | 18 | Under 11 | $16K |
| Tien T Le Corvallis, OR | Family Practice | 16 | Under 11 | $15K |
| Inna Kigel Kew Gardens, NY | Family Practice | 12 | Under 11 | $15K |
| Dmitriy Fuzaylov Rego Park, NY | Pain Management | 35 | Under 11 | $15K |
| Solomon N Forouzesh Culver City, CA | Rheumatology | 13 | Under 11 | $13K |
| Taylor A Patterson Peoria, AZ | Family Practice | 13 | Under 11 | $13K |
| Ross B Vaughn Tuscaloosa, AL | Internal Medicine | 12 | Under 11 | $13K |
| Natalie A Morgan Salina, KS | Obstetrics & Gynecology | 13 | Under 11 | $13K |
| Astrik Davtian Glendale, CA | Internal Medicine | 13 | Under 11 | $12K |
| Sebastian K John Baltimore, MD | Internal Medicine | 13 | Under 11 | $12K |
| Walter L Chmelewski Raleigh, NC | Rheumatology | 11 | Under 11 | $12K |
| Jeanne M Denk Watertown, WI | Nurse Practitioner | 12 | Under 11 | $12K |
| Habiba Seidu-Fuseini Chicago, IL | Nurse Practitioner | 13 | Under 11 | $12K |
| John K Gearhart Tulsa, OK | Family Practice | 13 | Under 11 | $12K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,518 | 16,327 | 4,201 | $17.4M |
| 2023 | 4,027 | 13,851 | 3,640 | $16.2M |
| 2024 | 3,709 | 11,908 | 3,369 | $13.7M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Viatris Special | 6,177 | $7.7M |
| Pfizer/Viatris | 5,738 | $6.1M |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 9
- RxNorm concept IDs
- 205322, 205323, 213468, 213469, 349514
- Application numbers
- NDA020998
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 132,409 side-effect reports named celecoxib, the active ingredient of Celebrex (reports from 2003 on). 93,030 of them (70.3%) were serious, 12,746 named a death and 40,925 named a hospital stay. The reactions named most often were drug ineffective, pain and arthralgia. 29,561 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
132,409
6,704 in 2025 (+1.9% from 2024)
Serious
70.3%
93,030 reports
Deaths named
12,746
9.6% of reports
Hospital stays
40,925
30.9% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Celebrex?
132,409 reports from 2003 through September 2026 named celecoxib, the active ingredient of Celebrex. 93,030 of them (70.3%) were serious, 12,746 named a death and 40,925 named a hospital stay.
What are the most reported side effects of Celebrex?
18,273 reports named drug ineffective, the reaction named most often, followed by pain (12,764) and arthralgia (11,407). In the last 5 years the reaction named most often was off label use (5,092 reports). A report can name several reactions.
How many side-effect reports named Celebrex in 2025?
6,704 reports were received in 2025 (+1.9% from 2024). 2026 so far: 4,058 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Celebrex caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Celebrex caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with celecoxib: Celecoxib, Elyxyb
- Makers on the stock market:
SCLX·SCLX drug pipeline - Drug approvals (18 approvals on file for celecoxib) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (celecoxib) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.